SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer

<div>SFRP4 is overexpressed in gastric cancer tissues. (a) SFRP4 expression in representative gastric tumor and paracancerous tissues (immunohistochemical staining, x20). (b) SFRP4 expression differences in tumor and paracancerous tissues (<i>n</i> = 137).</div>

Journal of Oncology

fig1

Figure 1

Figure 1: SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer 